arrow
M

Mehdi Benlarbi

u mass chan medical school
H指数:22
被引数:2,502

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC

HIV-1 Env的对称性开启由一种强效的CD4模拟物实现,这使抗共受体结合位点抗体能够介导ADCC。

2025-12-010
OAAI
Conformational dynamics of the HIV-1 envelope glycoprotein from CRF01_AE is associated with susceptibility to antibody-dependent cellular cytotoxicity

CRF01_AE型HIV-1包膜糖蛋白的构象动力学与抗体依赖性细胞介导的细胞毒性敏感性相关

2025-12-010
PRE
Anti-cluster A and anti-p24 antibodies in people with multidrug-resistant HIV: preliminary observations from the PRESTIGIO Registry

抗A簇抗体和抗p24抗体在多重耐药HIV感染者中的初步观察:PRESTIGIO登记研究的初步结果

2025-11-030
PRE
Optimization of VE607 to generate analogs with improved neutralization activities against SARS-CoV-2 variants

VE607优化以生成对SARS-CoV-2变体具有增强中和活性的类似物

2025-10-010
PRE
CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies
MBIO
IF4.7
2024-11-130
OAAI
The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity
2024-10-220
PRE
Three families of CD4-induced antibodies are associated with the capacity of plasma from people living with HIV to mediate ADCC in the presence of CD4-mimetics

CD4-induced抗体的三个家族与HIV感染者血浆在存在CD4-mimetics的情况下介导ADCC的能力有关。

2024-10-222
OA
NTB-A and 2B4 Natural Killer Cell Receptors Modulate the Capacity of a Cocktail of Non-Neutralizing Antibodies and a Small CD4-Mimetic to Eliminate HIV-1-Infected Cells by Antibody-Dependent Cellular Cytotoxicity
2024-07-201
OAAI
Sustained IFN signaling is associated with delayed development of SARS-CoV-2-specific immunity

持续的IFN信号传导与SARS-CoV-2-specific免疫的延迟发展有关

2024-05-163
OAAI
Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis
2024-02-237
OAAI
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia
2023-11-306
OAAI